Skip to main content
. 2016 Nov 11;7(51):85283–85290. doi: 10.18632/oncotarget.13297

Table 2. Univariate cox regression analysisof prognostic factors for overall survival rates of astrocytoma patients.

Variety Classification Death cases/Total cases Median survival time 1 year/3 year overall survival p HR(95%CI)
Total / 147/160 11 28.8%/6.6% / /
Sex Male 80/88 11 26.1%/6.8% 0.769 1
Female 67/72 11 31.9%/6.3% 1.05(0.76-1.44)
Age < 40years 58/66 11 31.8%/8.6% 0.186 1
≥40years 89/94 10 26.6%/- 1.23(0.88-1.71)
WHO classification extent of surgical resection I-II grade 86/96 11 28.1%/ 0.612 1
III grade 61/64 11 29.7%/3.9% 1.08(0.78-1.50)
Not all resection 98/111 9 16.3%/- 0.003 1
Total resection 49/49 11 34.2%/9.6% 0.61(0.43-0.88)
Radiotherapy No 11/14 12 46.2%/- 0.334 1
Conformal radiotherapy 38/41 9 14.6%/8.8% 1.48(0.75-2.91)
Gamma knife 99/106 11 32.1%/- 1.18(0.63-2.21)
Chemotherapy No 96/102 9 23.5%/- 0.029 1
Yes 51/58 12 37.9%/11.4% 0.71(0.49-0.99)

p<0.05 indicates statistical significance; HR: hazard ratios; CI: confidence interval.